Jordan Chambers
Predoctoral Trainee
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

Websites
favorite icon LinkedIn

ORCID ORCID Icon : 0000-0002-4285-7454



Jordan Chambers is currently a doctoral student pursuing a PhD in Molecular and Translational Medicine. She is working with Dr. Colucci studying the mechanism of cardiac remodeling and heart failure, with a particular interest in the role of oxidative stress in heart disease. She obtained her B.S in Biomedical Science with honors research distinction at The Ohio State University in 2014, where she researched a novel therapeutic pathway in Dilated Cardiomyopathy.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Baka T, Moore J, Qin F, Yurista SR, Zhang A, He H, Chambers JM, Croteau D, Goel RK, Smith H, Wang MC, Chen CS, Hobai IA, Rombaldova M, Kuda O, Tardiff JC, Balschi JA, Pimentel DR, Seidman CE, Seidman JG, Emili A, Colucci WS, Luptak I. Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model. Eur Heart J. 2025 Oct 22; 46(40):4105-4119.View Related Profiles. PMID: 40396194
     
  2. Chambers JM, Croteau D, Pimentel DR, Gower AC, Panagia M, Baka T, Qin F, Luptak I, Colucci WS. SGLT2 inhibitor upregulates myocardial genes for oxidative phosphorylation and fatty acid metabolism in Gaq-mice. J Mol Cell Cardiol Plus. 2025 Jun; 12:100296.View Related Profiles. PMID: 40291834; PMCID: PMC12022632; DOI: 10.1016/j.jmccpl.2025.100296;
     
  3. Croteau D, Baka T, Young S, He H, Chambers JM, Qin F, Panagia M, Pimentel DR, Balschi JA, Colucci WS, Luptak I. SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy. Biomed Pharmacother. 2023 Apr; 160:114310.View Related Profiles. PMID: 36731341; PMCID: PMC9992115; DOI: 10.1016/j.biopha.2023.114310;
     
  4. Croteau D, Luptak I, Chambers JM, Hobai I, Panagia M, Pimentel DR, Siwik DA, Qin F, Colucci WS. Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice. J Am Heart Assoc. 2021 07 06; 10(13):e019995.View Related Profiles. PMID: 34169737; PMCID: PMC8403324; DOI: 10.1161/JAHA.120.019995;
     
  5. Goodman JB, Qin F, Morgan RJ, Chambers JM, Croteau D, Siwik DA, Hobai I, Panagia M, Luptak I, Bachschmid M, Tong X, Pimentel DR, Cohen RA, Colucci WS. Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure Overload-Induced Myocardial Failure in Mice. Circulation. 2020 12 22; 142(25):2459-2469.View Related Profiles. PMID: 33076678; PMCID: PMC7752816; DOI: 10.1161/CIRCULATIONAHA.120.048183;
     
  6. Croteau D, Qin F, Chambers JM, Kallick E, Luptak I, Panagia M, Pimentel DR, Siwik DA, Colucci WS. Differential Effects of Sacubitril/Valsartan on Diastolic Function in Mice With Obesity-Related Metabolic Heart Disease. JACC Basic Transl Sci. 2020 Sep; 5(9):916-927.View Related Profiles. PMID: 33015414; PMCID: PMC7524781; DOI: 10.1016/j.jacbts.2020.07.006;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 6 publications over 4 distinct years, with a maximum of 2 publications in 2020 and 2025

YearPublications
20202
20211
20231
20252

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

ABCB10
Heart failure
Metabolic heart disease
Contact for Mentoring:

Chambers's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (43) concept(s)
_
Co-Authors
See all (13) people
_
Similar People
See all (60) people
_